MICONAZOLE NITRATE

The Defense Logistics Agency awarded a delivery order under base contract SPE2DX-25-D-9900 to DMS Pharmaceutical Group Inc. (CAGE 1UNB0) for the procurement of 4.000 units of Miconazole Nitrate (NSN 6505010498881) at a total price of $16.12, with delivery required by July 29, 2026. The item is to be shipped FOB destination, meaning the contractor assumes all transportation costs and risk until delivery at the designated location: Fort Bragg, North Carolina. No specific technical, packaging, preservation, or labeling standards beyond traceable shipping and mandatory marking of NSN, NDC, and CAGE codes are detailed, and no MIL-STDs are cited in the document. The order is treated as a simplified acquisition, with award likely based on lowest price technically acceptable, given the nominal value and commercial nature of the pharmaceutical item. The contractor has certified status as a small business, women-owned small business, and small disadvantaged business, triggering compliance obligations under FAR Part 19. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, via a voucher-based system without explicit electronic invoicing. The contracting officer is Lisa Quinn, and administrative support is provided by Shairy M. Cartagena, though no formal COR or COTR is designated. The order does not include explicit FAR clauses, special requirements, evaluation factors, or attachments, suggesting reliance on underlying contract terms and standard DLA administrative procedures.